Inhibitor probes for imaging sodium-glucose cotransporters in health and disease
AssigneeThe Regents of the University of California
InventorsErnest M. Wright, Jorge R. Barrio
Life of this patent
Estimating the term…
Abstract
Radiolabeled tracers for binding to sodium/glucose cotransporters (SGLTs), and their synthesis, are provided. The tracers are high-affinity inhibitors of SGLTs, glycosides labeled with radioactive halogens. Also provided are in vivo and in vitro techniques for using the tracers as analytical tools to study the biodistribution and regulation of SGLTs in health and disease, and to evaluate therapeutic interventions. The ability to monitor radiolabel tracer disposition in real time enables the design of new SGLT inhibitors with lower metabolism and higher efficiency.
Claims13
A radiolabeled sodium/glucose cotransporter inhibitor comprising a six membered sugar ring connected to a Ring A which is in turn connected to a Ring B wherein the inhibitor is a compound of the formula:
- Where X═—O—, —S—, —C—, CH2, C—(H)alkyl, C(alkyl)2), —NH— or N-alkyl,
- 1A, 1B, 2A, 2B, 3A and 3B═—H, —OH, —O—, alkyl, —F, —18F, —I, —123I, —124I or Z connected to the Ring A and Ring B moiety)
- 4A and 4B═—H, —OH, —F, 18F, —I, —123I, —124I, or Z connected to the Ring A and Ring B moiety, and
- 5A and 5B═—H, —OH, —CH2OH, —F, 18F, —I, 123I, —124I—CH2, —CH218F, —CH2I, CH2123I, CH2124I, Z or CH2Z, where Z is connected to the Ring A and Ring B moiety, and D- and L- isomers thereof,
- Where Ring A and Ring B are selected from:
- Phenyl rings,
- Heterocyclic rings which can be a pyrrole, imidazole, thioimidazole, pyridine, furane, oxazole, pyrimidine or pyrolidine rings, or
- Fused aromatic rings which can be a naphthalene, benzothiazole, benzopyrazole, quinoline, benzoxazole or indole rings,
- Where the R substitutions in Ring A and Ring B are one or more halogens selected from the group consisting of F, Br, I or 18F, 123I, 124I, 75Br or an alkyl, alkoxy, alkylamine, alkylthio, aryl, or a heterocyclic ring,
- Where the Y link is —CH2, alkyl substituted CH2, —NH, N-alkyl, —O—, —S—, or
- Where the Z link comprises either
- Ring A attached directly to C1, C2, C3, C4, C5 or C5CH2— in the six member sugar ring ,
- or
- Ring A attached to C1, C2, C3, C4, C5, C5CH2— via Z where is Z is CH2, or an alkyl substituted CH2, —NH, N-alkyl, —O—, or —S—.
A method of monitoring sodium/glucose cotransporter activity in a mammal, in vivo, comprising:
- administering to a mammal a bolus of a tracer for SGLT activity, and a compound which is an inhibitor for sodium/glucose cotransporter 2 (SGLT2), but not an inhibitor of sodium/glucose cotransporter 1 (SGLT1);
- generating radiographic data indicative of tracer uptake in the mammal by scanning the mammal using a radiographic technique;
- and, using the radiographic data to assess the distribution of SGLT1 and SLGT2 in the mammal, the radiographic technique comprising one or more computerized methods.
Synthesis of radiolabeled, [18F]- dapagliflozin ((1S)-1,5-anhydro-1-C-{4-chloro-3[(4-ethoxyphenyl)methyl]phenyl}-[18F]-4-deoxy-D-glucitol) comprising the procedure as set forth in FIG. 4.
Dependencies are inferred from the claim text.